CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,807 | -57.7% | 73,494 | -43.7% | 0.00% | – |
| Q2 2023 | $224,391 | -50.6% | 130,460 | -56.6% | 0.00% | – |
| Q1 2023 | $454,270 | -54.1% | 300,841 | -51.3% | 0.00% | -100.0% |
| Q4 2022 | $989,399 | +39.4% | 618,374 | +26.3% | 0.00% | 0.0% |
| Q3 2022 | $710,000 | +56.7% | 489,630 | +97.8% | 0.00% | 0.0% |
| Q2 2022 | $453,000 | -0.2% | 247,477 | +45.6% | 0.00% | – |
| Q1 2022 | $454,000 | +238.8% | 169,951 | +546.3% | 0.00% | – |
| Q3 2021 | $134,000 | -88.8% | 26,297 | -86.1% | 0.00% | -100.0% |
| Q2 2021 | $1,199,000 | -51.3% | 189,444 | -40.5% | 0.00% | -50.0% |
| Q1 2021 | $2,462,000 | -39.0% | 318,481 | -48.3% | 0.00% | -50.0% |
| Q4 2020 | $4,035,000 | +18.4% | 615,999 | +20.2% | 0.00% | +33.3% |
| Q3 2020 | $3,408,000 | +12.1% | 512,488 | +40.4% | 0.00% | -25.0% |
| Q2 2020 | $3,041,000 | -24.1% | 365,097 | -30.1% | 0.00% | -33.3% |
| Q1 2020 | $4,008,000 | -31.1% | 522,652 | -25.3% | 0.01% | -14.3% |
| Q4 2019 | $5,818,000 | +133.9% | 700,101 | +107.7% | 0.01% | +133.3% |
| Q3 2019 | $2,487,000 | -33.3% | 337,004 | +1.4% | 0.00% | -40.0% |
| Q2 2019 | $3,727,000 | -8.7% | 332,194 | -12.5% | 0.01% | 0.0% |
| Q1 2019 | $4,082,000 | +102.2% | 379,754 | +184.1% | 0.01% | +66.7% |
| Q4 2018 | $2,019,000 | -10.8% | 133,682 | +9.3% | 0.00% | 0.0% |
| Q3 2018 | $2,263,000 | -8.4% | 122,317 | +13.2% | 0.00% | 0.0% |
| Q2 2018 | $2,470,000 | +12.0% | 108,053 | +39.4% | 0.00% | 0.0% |
| Q1 2018 | $2,205,000 | +242.9% | 77,515 | +154.3% | 0.00% | +200.0% |
| Q4 2017 | $643,000 | +183.3% | 30,481 | +144.2% | 0.00% | – |
| Q3 2017 | $227,000 | -48.9% | 12,483 | -41.3% | 0.00% | -100.0% |
| Q4 2015 | $444,000 | – | 21,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |